Featured Research

from universities, journals, and other organizations

The Fabled Myrrh May Fight Cholesterol

Date:
October 25, 2000
Source:
University Of Pennsylvania Medical Center
Summary:
The extract from a tree in the fabled myrrh family is being investigated by researchers at the University of Pennsylvania School of Medicine for properties that may lower cholesterol.

The extract from a tree in the fabled myrrh family is being investigated by researchers at the University of Pennsylvania School of Medicine for properties that may lower cholesterol.

Dr. Philippe Szapary, Assistant Professor of Medicine at Penn who writes frequently about the use of alternative medicine in treating cardiovascular disease, is in the midst of a study of the dietary supplement gugulipid, an extract from the gummy resin of the thorny mukul myrrh bush of western India that has made its way into American health-food stores.

The bitter-tasting, fragrant myrrh is used in incense and perfumes – in the Christian tradition, a form of sweet-scented myrrh was presented by the three wise men to the infant Jesus – and the mukul myrrh, specifically, has a 2,000-year history in traditional Indian medicine. Ayurvedic health practitioners, who combine meditation, yoga and diet to address physical illness, use the resin extract in treating artherosclerosis, obesity and arthritis.

In the 1960s and ‘70s, Indian scientists were able to identify two properties of the extract – which, combined, they named gugulipid -- that appeared to aid in lowering cholesterol.

“This is something that’s been around for thousands of years, and when some scientists looked into it, they actually found a scientific basis for its effectiveness,” said Szapary. “But there’s still not enough documentation. We’re trying, in a methodical way, to establish that basis.” His work has been recognized by the National Center for Complementary and Alternative Medicine (NCCAM), which recently awarded him a five-year research grant of about $150,000 for each year.

“In this country, supplements such as gugulipid are regarded as ‘herbs’ rather than drugs, which means they aren’t currently regulated by the Food and Drug Administration,” Szapary said. “My interest is to gather enough evidence to demonstrate whether a gugulipid extract is safe and effective, in the short term, for use by Americans with mild-to-moderately elevated cholesterol.” His work with gugulipid, which began last spring, is designed to assess the drug through a simple, randomized study using 90 subjects.

Participants are divided into three groups; the first is administered a placebo, the second a standard dosage of gugulipid, and the third a higher dosage of the supplement. Each participant remains on the regimen for two months while blood tests indicate its effectiveness. Thus far 60 people have taken part.

“The participants have uniformly felt like they’ve been able to tolerate the medicine with few side effects,” he said. The study -- which began prior to Szapary’s grant from the NCCAM -- is funded in part by the General Clinical Research Center at Penn, which, in turn, is funded by the National Institutes of Health, and by the Sabinsa Corp., a manufacturer of gugulipid.

Editor’s note: Dr. Szapary has no financial interest in the Sabinsa corporation.


Story Source:

The above story is based on materials provided by University Of Pennsylvania Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of Pennsylvania Medical Center. "The Fabled Myrrh May Fight Cholesterol." ScienceDaily. ScienceDaily, 25 October 2000. <www.sciencedaily.com/releases/2000/10/001025072356.htm>.
University Of Pennsylvania Medical Center. (2000, October 25). The Fabled Myrrh May Fight Cholesterol. ScienceDaily. Retrieved July 31, 2014 from www.sciencedaily.com/releases/2000/10/001025072356.htm
University Of Pennsylvania Medical Center. "The Fabled Myrrh May Fight Cholesterol." ScienceDaily. www.sciencedaily.com/releases/2000/10/001025072356.htm (accessed July 31, 2014).

Share This




More Health & Medicine News

Thursday, July 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

House Republicans Vote to Sue Obama Over Healthcare Law

House Republicans Vote to Sue Obama Over Healthcare Law

Reuters - US Online Video (July 31, 2014) The Republican-led House of Representatives votes to sue President Obama, accusing him of overstepping his executive authority in making changes to the Affordable Care Act. Mana Rabiee reports. Video provided by Reuters
Powered by NewsLook.com
Despite Health Questions, E-Cigs Are Beneficial: Study

Despite Health Questions, E-Cigs Are Beneficial: Study

Newsy (July 31, 2014) Citing 81 previous studies, new research out of London suggests the benefits of smoking e-cigarettes instead of regular ones outweighs the risks. Video provided by Newsy
Powered by NewsLook.com
Dangerous Bacteria Kills One in Florida

Dangerous Bacteria Kills One in Florida

AP (July 31, 2014) Sarasota County, Florida health officials have issued a warning against eating raw oysters and exposing open wounds to coastal and inland waters after a dangerous bacteria killed one person and made another sick. (July 31) Video provided by AP
Powered by NewsLook.com
Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins